Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes

Oncogene

Volumn 33, Issue 32, 2014, Pages 4123-4131

  Bessede E ^a   Staedel, C ^b,c   Acuna Amador L A ^a   Nguyen, P H ^a   Chambonnier, L ^a   Hatakeyama, M ^d   Belleannee G ^e   Megraud F ^a   Varon, C ^a  

^a Bordeaux Institute of Oncology   (France)

^b INSERM U869   (France)

^c INSERM   (France)

^d UNIVERSITY OF TOKYO   (Japan)

^e HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

CD44; gastric cancer; infection

Indexed keywords

AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD44; BACTERIAL PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PHENOTYPE; STOMACH; STOMACH NEOPLASMS;

EID: 84905864501     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.380     Document Type: Article

References (33)

1. IARC'Working'Group. Schistosomes, liver flukes and Helicobacter pylori:Views and expert opinion of IARC Working Group on the evaluation of carcinogenic risks to humans. IARC Monographs (International Agency for Research on Cancer): Lyon, France 1994; 61: 177-240.
2. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115.
3. Gwack J, Shin A, Kim CS, Ko KP, Kim Y, Jun JK et al. CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case-control study in Korea. Br J Cancer 2006; 95: 639-641. (Pubitemid 44325905)
4. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the betacatenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 2007; 26: 4617-4626. (Pubitemid 47067401)
5. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300: 1430-1434. (Pubitemid 36638162)
6. Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol 2008; 10: 1573-1581. (Pubitemid 352006141)
7. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007; 39: 305-318. (Pubitemid 46897605)
8. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715. (Pubitemid 351636299)
9. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PloS One 2008; 3: e2888.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988. (Pubitemid 36418143)
11. Bellizzi A, Sebastian S, Ceglia P, Centonze M, Divella R, Manzillo EF et al. Co-expression of CD133(\+)/CD44(\+) in human colon cancer and liver metastasis. J Cell Physiol 2012; 228: 408-15s.
12. Hao J, Madigan MC, Khatri A, Power CA, Hung TT, Beretov J et al. In vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147. PloS One 2012; 7: e40716.
13. Kure S, Matsuda Y, Hagio M, Ueda J, Naito Z, Ishiwata T. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Int J Oncol 2012; 41: 1314-1324.
14. Meng E, Long B, Sullivan P, McClellan S, Finan MA, Reed E et al. CD44\+/CD24-ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin Exp Metastasis 2012; 29: 939-948.
15. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110. (Pubitemid 46067310)
16. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115. (Pubitemid 46067311)
17. Su YJ, Lai HM, Chang YW, Chen GY, Lee JL. Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 2011; 30: 3186-3199.
18. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 2009; 27: 1006-1020.
19. Klarmann GJ, Hurt EM, Mathews LA, Zhang X, Duhagon MA, Mistree T et al. Invasive prostate cancer cells are tumor initiating cells that have a stem cell-like genomic signature. Clin Exp Metastasis 2009; 26: 433-446.
20. Li C, Lee CJ, Simeone DM. Identification of human pancreatic cancer stem cells. Methods Mol Biol 2009; 568: 161-173.
21. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174. (Pubitemid 39549631)
22. Mitsuno Y, Yoshida H, Maeda S, Ogura K, Hirata Y, Kawabe T et al. Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells. Gut 2001; 49: 18-22. (Pubitemid 32601874)
23. Saito Y, Murata-Kamiya N, Hirayama T, Ohba Y, Hatakeyama M. Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. J Exp Med 2010; 207: 2157-2174.
24. Varon C, Dubus P, Mazurier F, Asencio C, Chambonnier L, Ferrand J et al. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology 2012; 142: 281-291.
25. Baud J, Varon C, Chabas S, Chambonnier L, Darfeuille F, Staedel C. Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. PloS One 2013; 8: e60315.
26. Yin Y, Grabowska AM, Clarke PA, Whelband E, Robinson K, Argent RH et al. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 2010; 59: 1037-1045.
27. Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF. Phosphorylation of tyrosine 972 of the Helicobacter pylori CagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol 2001; 42: 631-644. (Pubitemid 33064475)
28. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105: 1003-1008. (Pubitemid 351282071)
29. Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY, Yang WH et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol 2010; 12: 982-992.
30. Varon C, Duriez A, Lehours P, Menard A, Laye S, Zerbib F et al. Study of Helicobacter pullorum proinflammatory properties on human epithelial cells in vitro. Gut 2009; 58: 629-635.
31. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA et al. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 2008; 68: 379-387. (Pubitemid 351380064)
32. Ferrand J, Lehours P, Schmid-Alliana A, Mégraud F, Varon C. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PloS One 2011; 6: e29007.
33. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295: 683-686. (Pubitemid 34111828)